IN-VIVO BLOCKADE OF THALAMIC GABA(B) RECEPTORS INCREASES EXCITATORY AMINO-ACID LEVELS

Citation
G. Nyitrai et al., IN-VIVO BLOCKADE OF THALAMIC GABA(B) RECEPTORS INCREASES EXCITATORY AMINO-ACID LEVELS, European journal of pharmacology, 318(2-3), 1996, pp. 295-300
Citations number
31
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
318
Issue
2-3
Year of publication
1996
Pages
295 - 300
Database
ISI
SICI code
0014-2999(1996)318:2-3<295:IBOTGR>2.0.ZU;2-B
Abstract
The effect of intrathalamic application of GABA(B) receptor antagonist s on the basal excitatory amino-acid levels was studied using microdia lysis probes implanted in the dorsal lateral geniculate nucleus and in the ventrobasal complex. In both nuclei, continuous perfusion of the GABA(B) receptor antagonist 3-aminopropyl-(diethoxymethyl)-phosphinic acid (CGP 35348) produced an increase in the extracellular concentrati on of aspartate and (to a lesser extent) glutamate, but no change was observed in the level of taurine, the main amino acid involved in the regulation of brain osmolarity processes. In contrast, mino-2-hydroxy- 2-(4-chlorophenyl)-propanesulphonic acid (2-hydroxy-saclofen), another GABA(B) receptor antagonist, failed to affect the extracellular conce ntration of aspartate, glutamate and taurine. Thus, the basal level of excitatory amino acids in the thalamus in vivo is under the control o f CGP 35348-sensitive GABA(B) receptors.